Skip to main content
VCbacked
Log inGet Started

Diagonal Therapeutics

Watertown, United States

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

$125.0M raised
Jan 2026
Series B
BiopharmaBiotechnologyLife ScienceMedicalTherapeutics

Top Investors

Lightspeed Venture PartnersRA Capital ManagementJanus Henderson InvestorsFrazier Life SciencesEcoR1 Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Diagonal Therapeutics

How much funding has Diagonal Therapeutics raised?
Diagonal Therapeutics has raised $125.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.
Who are Diagonal Therapeutics's investors?
Diagonal Therapeutics's investors include Lightspeed Venture Partners, RA Capital Management, Janus Henderson Investors, Frazier Life Sciences, EcoR1 Capital.
Where is Diagonal Therapeutics headquartered?
Diagonal Therapeutics is headquartered in Watertown, United States.
What does Diagonal Therapeutics do?
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
What stage is Diagonal Therapeutics at?
Diagonal Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Diagonal Therapeutics — Funding & Investors." VCBacked, January 8, 2026, https://www.vcbacked.co/company/diagonal-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2026). Diagonal Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/diagonal-therapeutics
Wikipedia (cite web)
{{cite web |title=Diagonal Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/diagonal-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego